Med Biogene Inc (CVE:MBI)’s share price reached a new 52-week low during trading on Monday . The company traded as low as C$0.03 and last traded at C$0.03, with a volume of 0 shares trading hands. The stock had previously closed at C$0.03.
Med Biogene Company Profile (CVE:MBI)
Med BioGene Inc, a life science company, focuses on the development and commercialization of genomic-based clinical laboratory diagnostic tests for cancer. Its products include the GeneFx Lung, a gene expression-based test for early-stage non-small-cell lung cancer that assists in identifying patients for adjuvant chemotherapy.
See Also: How prevalent are 12b-1 fees?
Receive News & Ratings for Med Biogene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Med Biogene and related companies with MarketBeat.com's FREE daily email newsletter.